As of 2025-07-15, the EV/EBITDA ratio of Zosano Pharma Corp (ZSAN) is 0.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ZSAN's latest enterprise value is -9.06 mil USD. ZSAN's TTM EBITDA according to its financial statements is -28.51 mil USD. Dividing these 2 quantities gives us the above ZSAN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.5x - 24.9x | 22.6x |
| Forward P/E multiples | 23.2x - 28.1x | 24.8x |
| Fair Price | (132.70) - (142.59) | (135.20) |
| Upside | -23897.8% - -25671.7% | -24346.5% |
| Date | EV/EBITDA |